Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Chelirubine" patented technology

Flavoprotein oxidase genes of macleaya cordata in synthesis of sanguinarine and chelerythrine and application of flavoprotein oxidase genes

ActiveCN106047904AAchieve synthesisAchieve in vitro synthesisOxidoreductasesGenetic engineeringHeterologousFlavoprotein
The invention discloses flavoprotein oxidase genes of macleaya cordata in synthesis of sanguinarine and chelerythrine and application of the flavoprotein oxidase genes. Three flavoprotein oxidase genes joining in synthesis of sanguinarine and chelerythrine are found in a macleaya cordata genome for the first time, including genes Mc20113, Mc6407 and Mc6408. Steps of reaction are respectively verified by using a brewer's yeast system through upstream precursor feeding, and synthesis of sanguinarine and chelerythrine and midbodies can be achieved. The conversion efficiency of same functional genes of macleaya cordata and opium poppy is further compared by using a brewer's yeast heterologous expression system, and the result shows that the conversion rate of the gene of macleaya cordata is remarkably higher than that of opium poppy. The invention further discloses a molecular mechanism of synthesis of sanguinarine in macleaya cordata, and a theoretic basis and molecular assistant breeding targets are provided for breeding of macleaya cordata with high contents of sanguinarine and chelerythrine; and meanwhile, precious experience is provided for in-vitro artificial synthesis of sanguinarine and chelerythrine.
Owner:MICOLTA BIORESOURCE INC LTD

Sanguinarine alcoholate and chelerythrine alcoholate and preparation method and application thereof in animal acaricidal drugs

The invention relates to a sanguinarine alcoholate and a chelerythrine alcoholate and a preparation method and application thereof in acaricidal drugs for animals. Livestock and poultry acariasis is an in vitro parasitic disease which can cause serious damage to the animal health, and serious stress response of animals to influence ingestion, feed efficiency and weight gain, even cause death. At present, the control of the animal acariasis mainly relies on drugs for killing ticks and mites, and the ticks and mites can produce resistance to the drugs after the drugs are used for a long time, so that the drugs can cause adverse environmental and ecological effects, and can only drive and kill polypides instead of ova. The sanguinarine alcoholate and the chelerythrine alcoholate are derived from natural compounds-sanguinarine and chelerythrine alcoholate, and exist in the form of free alkaloids in the acaricidal drugs for animals. The sanguinarine alcoholate and the chelerythrine alcoholate have the characteristics of low toxicity, low residue and not easy production of resistance to the drugs of natural drugs, and have remarkable acaricidal activity and good treatment effect on the acariasis of animals when the sanguinarine alcoholate and the chelerythrine alcoholate are applied as the acaricidal drugs for animals.
Owner:NORTHWEST A & F UNIV

Method for preparing chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals

The invention discloses a method for preparing a chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals. The medicament consists of chelerythrine and starch serving as an auxiliary material. The method for preparing the prevention and treatment agent comprises the following steps of: weighing chelerythrine extract (the purity is 80 percent) and starch serving as the auxiliary material, adding the chelerythrine extract and the starch into a mixer, and mixing the chelerythrine extract and the starch uniformly to obtain a preparation containing 5 to 20 percent chelerythrine. When the bacterial disease prevention and treatment agent is added into feed for feeding, the dosage is 200 to 250 mg/kg (according to the quantity of the chelerythrine for each kilogram of weight); the prevention and treatment agent added in the feed has low toxicity, does not affect the quality of aquatic products, has no residue or pollution, is not easy to generate medicament resistance, does not affect the feed and growth of the aquatic animals, has low dosage, and is widely applied in prevention and treatment of bacterial hemorrhage diseases of mandarin fish, weever, carp, grass carp, eel, porgy, flounder and the like.
Owner:PEARL RIVER FISHERY RES INST CHINESE ACAD OF FISHERY SCI

Optimized sequence of macleaya cordata dihydrobenzophenanthridine oxidase gene and application thereof

The invention provides an optimized sequence of a macleaya cordata dihydrobenzophenanthridine oxidase gene and application thereof. The invention comprises codon optimization on a dihydrobenzophenanthridine oxidase gene MC6408 to obtain an optimized sequence MC6408opt, a recombinant expression vector of the optimized sequence MC6408opt, yeast engineering bacteria containing the recombinant expression vector of the optimized sequence MC6408opt, and application of the optimized sequence MC6408opt, recombinant expression vector and yeast engineering bacteria in the preparation of pseudochelerythrine. The functional gene MC6408 of macleaya cordata participating in synthesis of pseudochelerythrine and chelerythrine is subjected to codon optimization according to a yeast preferred codon to obtain the optimized sequence; and the optimized sequence is integrated into saccharomyces cerevisiae for heterologous expression, so that microbial transformation of the pseudochelerythrine and chelerythrine is realized. Compared with an unoptimized functional gene, the optimized gene can greatly improve the enzymatic efficiency of the dihydrobenzophenanthridine oxidase, increase the content of the catalytic product pseudochelerythrine, and reduce the production cost of the pseudochelerythrine.
Owner:MICOLTA BIORESOURCE INC LTD

High-efficiency enzyme-catalyzed method for synthesizing sanguinarine and chelerythrine

A highly efficient method for catalyzing the synthesis of sanguinarine and chelerythrine, comprising: from the known protopine-6-hydroxylase gene, dihydrobenzophenanthridine oxidase gene and cytochrome P450 reductase gene, by means of heterologous expression and result comparison and analysis, screening out an optimal gene having high expression efficiency, then performing codon optimization on the selected optimal gene; constructing the optimal gene sequence on an expression vector, then transferring same into yeast engineering bacteria for transformation so as to obtain recombinant yeast engineering strains; finally, feeding the recombinant yeast engineering bacteria by using a leaf raw material liquid precursor of Macleaya cordata for fermentation, so as to obtain a product. The invention improves the enzyme catalytic efficiency of sanguinarine and chelerythrine in various aspects such as gene level and fermentation process; the leaf raw material liquid, which is not a traditional medicinal part of Macleaya cordata, is directly used for fermentation with the engineering bacteria, and protopine and allocryptine having high alkaloid content in leaves are converted into high-value sanguinarine and chelerythrine to achieve the comprehensive utilization of Macleaya cordata resources.
Owner:MICOLTA BIORESOURCE INC LTD

Optimized Sequence of Boluohui Dihydrotriphenanthridine Oxidase Gene and Its Application

The invention provides an optimized sequence of a macleaya cordata dihydrobenzophenanthridine oxidase gene and application thereof. The invention comprises codon optimization on a dihydrobenzophenanthridine oxidase gene MC6408 to obtain an optimized sequence MC6408opt, a recombinant expression vector of the optimized sequence MC6408opt, yeast engineering bacteria containing the recombinant expression vector of the optimized sequence MC6408opt, and application of the optimized sequence MC6408opt, recombinant expression vector and yeast engineering bacteria in the preparation of pseudochelerythrine. The functional gene MC6408 of macleaya cordata participating in synthesis of pseudochelerythrine and chelerythrine is subjected to codon optimization according to a yeast preferred codon to obtain the optimized sequence; and the optimized sequence is integrated into saccharomyces cerevisiae for heterologous expression, so that microbial transformation of the pseudochelerythrine and chelerythrine is realized. Compared with an unoptimized functional gene, the optimized gene can greatly improve the enzymatic efficiency of the dihydrobenzophenanthridine oxidase, increase the content of the catalytic product pseudochelerythrine, and reduce the production cost of the pseudochelerythrine.
Owner:MICOLTA BIORESOURCE INC LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products